Cambium Networks Corporation CMBM
0.13 USD 0.00 (+0.00%)
Mar 30, 2026, 9:30 AM EDT
0.13 Day range 0.45
52-week range unavailable
- YTD
- -90.97%
- 1 year
- -63.54%
Analyst view
Price target (mean) 3.34 +2465.3% upside
Now 0.1301
- Target (low)
- 1.35
- Target (mean)
- 3.34
- Target (high)
- 7.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.13 | -0.13 – -0.13 | -0.95 | +86.3% | 42.98M | +6.9% | 4 |
| Next quarter | -0.13 | -0.14 – -0.12 | -0.46 | +71.7% | 44.45M | +5.0% | 3 |
| Current year | -0.902 | -0.98 – -0.72 | -1.10 | +18.0% | 174.97M | -20.5% | 5 |
| Next year | -0.1925 | -0.35 – -0.06 | -0.902 | +78.7% | 203.81M | +16.5% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 12, 2024 | Northland Capital Markets | Maintained | Outperform | Outperform |
| Aug 9, 2024 | Northland Capital Markets | Maintained | Outperform | Outperform |
| Aug 9, 2024 | Roth MKM | Maintained | Buy | Buy |
| May 10, 2024 | Roth MKM | Maintained | Buy | Buy |
| Feb 16, 2024 | Raymond James | Maintained | Outperform | Outperform |
| Jan 19, 2024 | Raymond James | Maintained | Outperform | Outperform |
| Nov 3, 2023 | Roth MKM | Maintained | Buy | Buy |
| Oct 10, 2023 | JP Morgan | Maintained | Underweight | Underweight |
| Oct 5, 2023 | Northland Capital Markets | Maintained | Outperform | Outperform |
| Oct 5, 2023 | Roth MKM | Maintained | Buy | Buy |
| Oct 5, 2023 | Oppenheimer | Downgrade | Outperform | Perform |
| Oct 5, 2023 | Raymond James | Maintained | Outperform | Outperform |
| Oct 5, 2023 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Aug 2, 2023 | Northland Capital Markets | Maintained | Outperform | Outperform |
| Aug 2, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 2, 2023 | Raymond James | Maintained | Outperform | Outperform |
| Aug 2, 2023 | JMP Securities | Maintained | Outperform | Outperform |
| Aug 2, 2023 | JP Morgan | Downgrade | Neutral | Underweight |
| May 9, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| May 9, 2023 | Raymond James | Maintained | — | Outperform |
| Apr 19, 2023 | JP Morgan | Maintained | — | Neutral |
| Feb 21, 2023 | Oppenheimer | Maintained | — | Outperform |
| Feb 17, 2023 | Oppenheimer | Maintained | — | Outperform |
| Feb 17, 2023 | Raymond James | Maintained | — | Outperform |
| Dec 20, 2022 | JP Morgan | Maintained | — | Neutral |
| Nov 15, 2022 | Raymond James | Downgrade | Strong Buy | Outperform |
| Jul 14, 2022 | JP Morgan | Maintained | — | Neutral |
| May 6, 2022 | Raymond James | Maintained | — | Strong Buy |
| May 6, 2022 | Oppenheimer | Maintained | — | Outperform |
| Apr 14, 2022 | Barrington Research | Downgrade | Outperform | Market Perform |